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To assess the use of extracorporeal cardiopulmonary resuscitation (ECPR), compared with manual or mechanical 41 
cardiopulmonary resuscitation (CPR), for out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) 42 
in adults and children. 43 
 44 
Methods 45 
The PRISMA guidelines were followed. We searched Medline, Embase, and Evidence-Based Medicine Reviews for 46 
randomized clinical trials and observational studies published before May 22, 2018. The population included adult 47 
and pediatric patients with OHCA and IHCA of any origin. Two investigators reviewed studies for relevance, 48 
extracted data, and assessed the quality of studies using the ROBINS-I tool. Outcomes included short-term and 49 
long-term survival and favorable neurological outcome. 50 
 51 
Results 52 
We included 25 observational studies, of which 15 studies were in adult OHCA, 7 studies were in adult IHCA, and 3 53 
studies were in pediatric IHCA. There were no studies in pediatric OHCA. No randomized trials were included. 54 
Results from individual studies were largely inconsistent, although several studies in adult and pediatric IHCA were 55 
in favor of ECPR. The risk of bias for individual studies was overall assessed to be critical, with confounding being 56 
the primary source of bias. The overall quality of evidence was assessed to be very low. Heterogeneity across 57 
studies precluded any meaningful meta-analyses. 58 
 59 
Conclusions 60 
There is inconclusive evidence to either support or refute the use of ECPR for OHCA and IHCA in adults and 61 
children. The quality of evidence across studies is very low.  62 
  63 
 4 
INTRODUCTION 64 
Extracorporeal cardiopulmonary resuscitation (ECPR) is an advanced rescue therapy, where an extracorporeal 65 
circuit is employed, to support circulation in patients with cardiac arrest refractory to conventional CPR.[1] ECPR 66 
maintains vital organ perfusion while potential reversible causes of the cardiac arrest can be identified and 67 
treated.  68 
 ECPR is recognized by the American Heart Association (AHA)[2, 3] and the European Resuscitation Council 69 
(ERC)[4, 5] as a therapy which can be considered in select cardiac arrest patients, when rapid expert deployment is 70 
possible. However, the benefits of applying ECPR are not clear and optimal patient selection and timing of the 71 
therapy are not well-understood.[6] Furthermore, the ethical considerations related to using and studying ECPR 72 
are complex.[7] Given the recent increase in the availability and usage of ECPR for cardiac arrest[8-10],  there is a 73 
need for a review of the evidence to guide the international consensus on ECPR in cardiac arrest.  74 
 The objective of this systematic review was to inform the update of the International Liaison Committee on 75 
Resuscitation (ILCOR) treatment recommendations by assessing the use of ECPR, compared to manual or 76 
mechanical cardiopulmonary resuscitation (CPR), for OHCA and IHCA of all causes in adults and children. 77 
 78 
METHODS 79 
Protocol and registration 80 
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 81 
(PRISMA) guidelines.[11] The PRISMA checklist is provided in the Supplementary Contents. The protocol and 82 
amendments were prospectively submitted to the International Prospective Register of Systematic Reviews 83 
(PROSPERO) (CRD42018085404). The protocol is provided in the Supplementary Contents. The review was 84 
commissioned by ILCOR.  85 
 86 
Eligibility criteria 87 
We used the PICO (Population, Intervention, Comparison, Outcome) format to frame the study question: Among 88 
adults (≥ 18 years) and children (< 18 years) with cardiac arrest in any setting (out-of-hospital or in-hospital) (P), 89 
does the use of ECPR, including extracorporeal membrane oxygenation or cardiopulmonary bypass, during cardiac 90 
arrest (I), compared to manual CPR and/or mechanical CPR (C), change survival at hospital discharge, long-term 91 
survival, neurological outcome at discharge, and/or long-term neurological outcome (O).  92 
 Outcomes with similar time frames (i.e. short-term [hospital discharge, 28-days, 30-days, and 1-month] and 93 
long-term [3-months, 6-months, and 1-year]) were combined into single categories. Long-term survival reported as 94 
hazard ratios (i.e. survival analysis), irrespective of length of follow-up, was also considered. Return of 95 
spontaneous circulation (ROSC) was not included as an outcome since it is difficult to meaningfully define in this 96 
patient population.  97 
 5 
 Randomized trials, non-randomized controlled trials, and observational studies (cohort studies and case-98 
control studies) with a control group (i.e. patients not receiving ECPR) were included. Animal studies, ecological 99 
studies, case series, case reports, reviews, abstracts, editorials, comments, and letters to the editor were not 100 
included. There were no limitations on publication period or study language. The population included patients with 101 
IHCA or OHCA of any origin, without age restriction. Studies with ≤ 5 patients receiving ECPR or studies that did not 102 
report timing of ECPR (i.e. not clear whether ECPR was used during or after cardiac arrest) were excluded.  103 
 Studies exclusively assessing the use of extracorporeal life support for cardiac and/or respiratory failure after 104 
sustained ROSC were not included. Studies reporting the use of extracorporeal circulation for accidental 105 
hypothermia, pulmonary embolism, overdoses, or other conditions were included if cardiac arrest was 106 
documented. Studies assessing cost-effectiveness of ECPR were considered for a descriptive summary. 107 
 108 
Information sources and search strategy 109 
We searched the following electronic bibliographic databases on December 19, 2017: Medline, Embase, and 110 
Evidence-Based Medicine Reviews (which includes the Cochrane Library). The search was repeated on May 22, 111 
2018 to capture any articles published during the review process. We used a combination of various search terms 112 
for cardiac arrest and extracorporeal circulation. The bibliographies of included articles were reviewed for 113 
potential additional articles. To identify ongoing trials, we searched the International Clinical Trials Registry 114 
Platform (http://www.who.int/ictrp/en/) (which includes entries in ClinicalTrials.gov) on March 13, 2018. The 115 
search strategies for each database and the Clinical Trials Registry Platform are provided in eTable 1–2 in the 116 
Supplementary Contents. 117 
  118 
Study selection 119 
Two reviewers, using pre-defined screening criteria, independently screened all titles and abstracts retrieved from 120 
the systematic review. The reviewers were blinded to authors and journal titles during the screening stage. Any 121 
disagreement regarding inclusion or exclusion were resolved via discussion between the reviewers and with a third 122 
reviewer as needed. The Kappa-value for inter-observer variance was calculated. In case of only weak or moderate 123 
agreement between reviewers (i.e. a Kappa < 0.80[12]) a third reviewer reviewed all excluded titles and abstracts 124 
to ensure optimized sensitivity. Two reviewers then reviewed the full text-reports of all potentially relevant 125 
publications passing the first level of screening. Any disagreement regarding eligibility was resolved via discussion.  126 
 127 
Data collection and data items 128 
Two reviewers using a pre-defined standardized data extraction form extracted data as pertinent to the PICO (see 129 
“Eligibility criteria”). Missing statistical parameters (i.e. odds ratios) of importance and variance measures (i.e. 130 
confidence intervals) were calculated if data permitted. Any discrepancies in the extracted data were identified 131 
and resolved with discussion and consensus.  132 
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 133 
Risk of bias in individual studies 134 
Two investigators independently assessed risk of bias for the included studies. Risk of bias was assessed by the 135 
ROBINS-I tool[13] for observational studies. In the ROBINS-I tool, risk of bias is assessed within specified domains, 136 
including (1) bias due to confounding, (2) bias in selection of participants into the study, (3) bias in classification of 137 
interventions, (4) bias due to deviations from intended interventions (5) bias due to missing data, (6) bias in 138 
measurement of outcomes, (7) bias in selection of the reported result, and (8) overall bias.[13] Bias assessments 139 
were tabulated with explanations when studies were downgraded. Since assessments are inherently subjective 140 
and there are no strict and objective criteria to judge bias within the ROBINS-I tool[13], disagreements were 141 
resolved via discussion between the two investigators. Bias was assessed per study rather than per outcome, since 142 
there were no meaningful differences in bias across outcomes. 143 
 144 
Data synthesis and confidence in cumulative evidence 145 
Studies were assessed for clinical (i.e. participants, interventions, and outcomes), methodological (i.e. study design 146 
or risk of bias), and statistical heterogeneity.[14] Separate meta-analyses were planned for adult IHCA, adult 147 
OHCA, pediatric IHCA, and pediatric OHCA as described in the protocol.  148 
 The quality of the overall evidence was assessed using the Grading of Recommendations Assessment, 149 
Development and Evaluation (GRADE) methodology ranging from very low quality of evidence to high quality of 150 
evidence.[15] Detailed assessment of overall risk of bias, inconsistency, indirectness, imprecision and potential 151 
other issues such as publication bias were tabulated. 152 
 Review Manager (The Cochrane Collaboration, 2014) was used to generate forest plots. 153 
 154 
RESULTS 155 
Study selection 156 
The search strategy identified 7,458 records of which 74 records were eligible for full-text review. The Kappa for 157 
identifying records during the initial screening of the first search was 0.38 prompting review by a third reviewer. A 158 
PRISMA diagram of the study selection process is presented in Figure 1. No randomized clinical trials were 159 
identified. Twenty-five observational studies met all of the inclusion criteria and none of the exclusion criteria.[16-160 
40] Fifteen studies were in adult OHCA[16-30], 7 studies were in adult IHCA[31-37], and 3 studies were in pediatric 161 
IHCA[38-40]. We identified no studies in pediatric OHCA. An overview of each included study is provided in Table 162 
1–3 and details are provided in the Supplementary Contents. We identified 5 ongoing clinical trials in adult OHCA 163 
on the International Clinical Trials Registry Platform. An overview of each trial is provided in Table 4. We did not 164 
identify any studies assessing the cost-effectiveness of ECPR in cardiac arrest. 165 
 166 
Adult out-of-hospital cardiac arrest 167 
 7 
Fifteen of the included studies were in adult OHCA.[16-30] Eight studies were performed in Asia[18-22, 24, 26, 27], 168 
4 studies in Europe[16, 17, 23, 25], and 3 studies in North America[28-30]. Three studies included both OHCA and 169 
IHCA patients.[17, 21, 28] The cohort and/or time-frame was overlapping for some studies.[19, 22, 27, 29, 30] 170 
Years of patient inclusion ranged from 1999 to 2015. The majority of studies defined the exposure as “ECPR use”, 171 
whereas one study[24] defined the exposure as “ECPR availability” and two studies[29, 30] defined exposure as a 172 
“ECPR strategy”. The median age of exposed patients ranged from 46 to 59 years. Twelve studies reported survival 173 
to hospital discharge, 6 studies reported long-term survival, 8 studies reported favorable neurological outcome at 174 
hospital discharge, and 6 studies reported long-term favorable neurological outcomes. All studies defined 175 
favorable neurological outcome as a Cerebral Performance Category score of 1–2. Forests plots of each outcome 176 
are presented in Figure 2. Additional details for each individual study are provided in Table 1 and the 177 
Supplementary Contents.   178 
 179 
Adult in-hospital cardiac arrest 180 
Seven of the included studies were in adult IHCA.[31-37] Six studies were performed in Asia[32-37] and one study 181 
was performed in Europe[31]. The cohort and/or time-frame was overlapping for some studies.[32, 33, 35-37] 182 
Years of patient inclusion ranged from 2001 to 2013. The majority of studies defined the exposure as “ECPR use”, 183 
whereas two studies[36, 37] defined the exposure as “ECPR attempt”. The median age of exposed patients ranged 184 
from 57 to 72 years. Six studies reported survival to hospital discharge, 6 studies reported long-term survival, 5 185 
studies reported favorable neurological outcome at hospital discharge, and 5 studies reported long-term favorable 186 
neurological outcome. Four studies reported survival analyses with length of follow-up ranging from 1 to 3 years. 187 
All studies defined favorable neurological outcome as a Cerebral Performance Category score of 1–2. Forests plots 188 
of each outcome are presented in Figure 3. Additional details for each individual study are provided in Table 2 and 189 
the Supplementary Contents.   190 
 191 
Pediatric in-hospital cardiac arrest 192 
Three of the included studies were in pediatric IHCA.[38-40] All studies were performed in North America, of which 193 
two studies[38, 40] were from the Get With The Guidelines® registry. Years of patient inclusion ranged from 2000 194 
to 2011. All studies defined the exposure as “ECPR use”. All studies reported survival to hospital discharge, 195 
whereas only one study reported favorable neurological outcome at hospital discharge. Favorable neurological 196 
outcome was defined as a Pediatric Cerebral Performance Category score of 1–3. Forests plots of each outcome 197 
are presented in Figure 4. Additional details for each individual study are provided in Table 3 and the 198 
Supplementary Contents.   199 
 200 
Risk of bias for individual studies 201 
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The risk of bias within individual studies was judged overall as critical for all studies, with confounding being the 202 
primary source. Risk of selection bias was judged to be low for the majority of studies. Few studies were at 203 
moderate risk of bias for missing data. The majority of studies did not report any missing data and were therefore 204 
classified as low risk of bias, but the risk of bias could also be considered “unknown”. All studies were at moderate 205 
risk for selective reporting since none provided a pre-registered protocol. The remaining ROBINS-I domains were 206 
all judged to be at low risk of bias. A detailed list of risk of bias assessments is provided in eTable 3 in the 207 
Supplementary Contents.  208 
 209 
Quality of evidence across studies 210 
The overall quality of evidence across all studies were judged to be of very low quality. GRADE summary tables and 211 
additional details are provided in eTable 4–6 in the Supplementary Contents. 212 
 213 
Meta-analyses, meta-regression, and publication bias 214 
The critical risk of bias and heterogeneity between studies did not allow for any meaningful meta-analyses. We 215 
were not able to conduct meta-regression or test for publication bias because too few studies were identified. 216 
 217 
DISCUSSION 218 
In this systematic review, we identified studies comparing the use of ECPR to manual or mechanical CPR for OHCA 219 
and IHCA in adult and pediatric patients. We identified 25 observational studies, of which 15 studies were in adult 220 
OHCA, 7 studies were in adult IHCA, and 3 studies were in pediatric IHCA. No randomized clinical trials were 221 
identified, though several are ongoing as noted on the International Clinical Trials Registry Platform. Results from 222 
studies in OHCA were inconsistent. Studies in adult and pediatric IHCA were generally in favor of ECPR, although 223 
the risk of bias for individual studies was overall assessed to be critical. The quality of evidence was very low across 224 
all outcomes.  225 
 The goal of ECPR is to support patients with cardiac arrest by providing time for recovery, diagnostics, and/or 226 
treatment of potentially reversible causes. The use of ECPR is complex and requires local expertise, specialized 227 
equipment, rigorous patient selection, and careful timing.[2, 3, 6] The location of cardiac arrest is of particular 228 
relevance in this context, since patients who experience OHCA are significantly different from patients who 229 
experience IHCA.[41-44] Patients with IHCA tend to have shorter low-flow time and are more likely to have rapid 230 
access to a dedicated ECPR response team. While the use of in-hospital extracorporeal life support has increased 231 
over the past decade[8-10], ECPR is not readily available for pre-hospital use and patients who experience OHCA 232 
are reliant on rapid transportation to ECPR capable hospitals[45].  233 
 The included studies were all assessed to have a critical risk of confounding potentially limiting internal 234 
validity. First, the final decision to perform ECPR is generally made on a case-by-case basis, which may limit the 235 
comparability between those receiving ECPR following a period of CPR and those with no ECPR. The factors driving 236 
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the decision to use ECPR are based on clinical assessments of the underlying disease, the assumption that 237 
conventional CPR will not be effective, and boundaries set by deployment protocols. These factors may be related 238 
to outcomes and could therefore bias the results. Second, many studies only reported unadjusted results[16-19, 239 
23-25, 27-30, 34, 39] or did not adjust adequately for important confounders. For instance, very few studies 240 
accounted for pre-cardiac arrest performance status or activities of daily living[22] and none of the studies 241 
adjusted for intra-cardiac arrest variables (e.g., end-tidal CO2, lactate, pH, potassium). In addition, studies 242 
accounting for past-medical history[21, 31, 32, 35-38], used crude measurements (e.g., renal disease vs. no renal 243 
disease, cardiac disease vs. no cardiac disease), which increases the risk of residual confounding. Third, most 244 
studies adjusted for “CPR duration”.[20-22, 26, 31-33, 35-38, 40] This is problematic, since “CPR duration” could be 245 
a mediator on the causal pathway between ECPR and outcomes[46] and because “CPR duration” is defined 246 
differently for patients receiving ECPR (time to ECPR, which was rarely well-defined) and no ECPR (time to ROSC or 247 
death). Adjusting for “CPR duration” using traditional methods is therefore likely to introduce biased results, 248 
although the direction of this bias can be difficult to predict.[47] Some studies also adjusted for treatments after 249 
the cardiac arrest (e.g., targeted temperature management)[20, 22, 26, 36, 37], which may bias the results, since 250 
these variables cannot be direct confounders of the relationship between ECPR and outcomes.[47] These 251 
limitations illustrate the need for rigorous randomized clinical trials or alternative study designs minimizing bias to 252 
clarify the role of ECPR in cardiac arrest.  253 
 The vast majority of the included studies were single-center studies[17-22, 25-37, 39], with varying inclusion 254 
criteria and settings. Some studies in adult OHCA restricted their inclusion criteria to patients with a witnessed 255 
cardiac arrest, very short no-flow times, and/or required a certain duration of conventional CPR prior to ECPR.[17, 256 
18, 22, 25, 26] Three studies assessed the availability and/or use of ECPR in the cardiac catheterization 257 
laboratory.[28-30] The results of these studies are not easily applicable to other settings. Studies in adult and 258 
pediatric IHCA were less diverse, although one adult study restricted inclusion to patients with cardiac arrest 259 
caused by acute pulmonary embolism.[33] ECPR technology[1] and costs[48] may also have varied across studies 260 
and time. The high-degree of heterogeneity between studies limited our ability to perform meta-analyses and 261 
reduced the generalizability of the included studies. 262 
 While we report on the use of ECPR in relation to outcomes, we did not evaluate patient selection, indication, 263 
and prognostication related to ECPR. A recent position paper by Abrams et al. has highlighted some of these 264 
issues, proposing that ECPR may be initiated by rapid-response teams within 15 minutes of conventional CPR in 265 
patients without severe comorbidities[6], although there is little evidence to support such a recommendation. 266 
Systematic reviews in IHCA[49] and OHCA[50] recently assessed prognostic factors of favorable outcome in adult 267 
patients receiving ECPR. Both reviews found initial shockable rhythms, short low-flow time, and low lactate values 268 
at admission to be associated with better outcomes. In the context of resource utilization, we did not identify any 269 
cost-effectiveness studies for ECPR specific to cardiac arrest. One study reported hospital costs without performing 270 
a cost-effectiveness analysis[51] and two studies conducted cost-effectiveness analyses for ECPR primarily 271 
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including non-cardiac arrest patients[52, 53]. Understanding the clinical benefits of ECPR relative to the resource 272 
utilization is particularly important given the recent increased use of ECPR. 273 
 274 
CONCLUSIONS 275 
There is inconclusive evidence to either support or refute the use of ECPR for OHCA and IHCA in adults and 276 
children. The quality of evidence across studies is very low. Future investigations should be cautious of issues 277 
related to internal validity. Randomized clinical trials are needed to better inform clinical practice.  278 
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FIGURE LEGENDS 451 
 452 
Figure 1. PRISMA diagram 453 
Out of 7458 screened records, 74 articles were assessed for eligibility, and 25 studies were included. 454 
 455 
Figure 2. Forest plots for adult out-of-hospital cardiac arrest 456 
Forest plots for survival to hospital discharge/one month (A), long-term survival (B), favorable neurological 457 
outcome at hospital discharge/one month (C), and long-term favorable neurological outcome (D) in adult out-of-458 
hospital cardiac arrest. The vertical red lines indicate odds ratios. Horizontal lines indicate 95% confidence intervals 459 
of the estimate. The studies are ordered by alphabetical order within each outcome. The forest plots for long-term 460 
outcomes are representative of all included patients, independent of survival to hospital discharge. The studies by 461 
Cesana et al. (2017), Lee et al. (2015), and Venturini et al. (2017) include both out-of-hospital cardiac arrest and in-462 
hospital cardiac arrest patients. There was some overlap between the studies by Hase (2005), Maekawa (2013) and 463 
Tanno (2008), and between Yannopolous (2016+2017).  464 
OHCA refers to out-of-hospital cardiac arrest. 465 
 466 
Figure 3. Forest plots for adult in-hospital cardiac arrest 467 
Forest plots for survival to hospital discharge/one month (A), long-term survival (B), favorable neurological 468 
outcome at hospital discharge/one month (C), long-term favorable neurological outcome (D), and survival analysis 469 
(E) in adult in-hospital cardiac arrest. The vertical red lines indicate odds ratios or hazard ratios. Horizontal lines 470 
indicate 95% confidence intervals of the estimate. For the survival analysis (hazard ratios from Cox proportional 471 
hazard models) with time-to-death as the outcome, estimates below 1 are in favor of ECPR. The studies are 472 
ordered by alphabetical order within each outcome. The forest plots for long-term outcomes are representative of 473 
all included patients, independent of survival to hospital discharge. There was some overlap between the studies 474 
by Chen (2008) and Lin (2010), and between Cho (2014) and Shin (2011+2013).  475 
IHCA refers to in-hospital cardiac arrest. 476 
 477 
Figure 4. Forest plots for pediatric in-hospital cardiac arrest 478 
Forest plots for survival to hospital discharge (A) and favorable neurological outcome at hospital discharge (B) in 479 
pediatric in-hospital cardiac arrest. The vertical red lines indicate odds ratios. Horizontal lines indicate 95% 480 
confidence intervals of the estimate. The studies are ordered by alphabetical order within each outcome. The 95% 481 
confidence interval reported by Ortmann et al. (medical-group) was non-symmetric and therefore re-estimated. 482 
There was some overlap between the studies by Lasa (2016) and Ortmann (2011).  483 
IHCA refers to in-hospital cardiac arrest. 484 
 485 
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TABLES 487 












Use of load-distributing 
band 






Age 18-75 years, 
witnessed, ischemic 
etiology, absence of 
comorbidities precluding 
ICU admission 






Non-traumatic, age ≤ 75, 
witnessed, bystander CPR 
or no-flow time ≤ 5 min, 
prehospital low-flow time 
≤ 30 min and > 10 min of 
conventional CPR at ED, 








ROSC within 10 min 













Age > 18 years, non-
traumatic 












Cardiac etiology, age > 16 
years, witnessed, CPR 
duration > 20 min 








Age > 18 years, ongoing 
CPR 






Shockable rhythm, cardiac 
arrest on arrival, 45 min 
from cardiac arrest onset 
to hospital arrival, no 
ROSC within 15 min after 
hospital arrival 
Age < 20 or > 75 
years, poor level of 
activities of daily 
living, non-cardiac 
etiology, body 
temperature < 30 C, 







Cardiac origin, CPR 
duration > 30 min 








Age 18-75 years, 
ventricular fibrillation, no-
flow time < 5 min, 
refractory cardiac arrest 
Head trauma or 
active bleeding, 













Age > 16 years, cardiac 
etiology 
















Age 18-75 years, cardiac 
etiology, shockable 
rhythm, 3 direct current 
shocks, amiodarone, 
eligible mechanical CPR, 












Age 18-75 years, cardiac 
etiology, shockable 
rhythm, 3 direct current 
shocks, amiodarone, 
eligible mechanical CPR, 
transfer time from scene 







E-CPR refers to extracorporeal cardiopulmonary resuscitation, CPR refers to cardiopulmonary resuscitation, ED 488 
refers to emergency department, ICU refers to intensive care unit, DNR refers to do-not-resuscitate, ROSC refers to 489 
return of spontaneous circulation; CCL refers to cardiac catheterization laboratory. 490 
a All studies compared ECPR vs. no ECPR whereas Sakamoto (2014) compared emergency departments with ECPR 491 
vs. emergency departments with no ECPR. 492 
b There was some overlap between the studies by Hase (2005), Maekawa (2013) and Tanno (2008), and between 493 
Yannopolous (2016+2017).  494 
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Germany 2009 – 2013 
Cardiovascular admission, 
witnessed 
Not Reported 353 
Chen,  
2008[32] 
Taiwan 2004 – 2006 
Age 18-75 years, CPR 















Taiwan 2006 – 2010 
Age > 18 years, acute 






damage, DNR, ROSC 




Taiwan 2004 – 2006 
Age 18-75 years, cardiac 
etiology, CPR duration > 10 
min, ROSC 




Korea 2003 – 2009 
Age 18-80 years, CPR 








with bleeding, septic 




E-CPR refers to extracorporeal cardiopulmonary resuscitation, CPR refers to cardiopulmonary resuscitation, DNR 495 
refers to do-not-resuscitate, ROSC refers to return of spontaneous circulation. 496 
a All studies compared ECPR vs. no ECPR whereas Shin et al. compared ECPR attempt vs. no ECPR attempt. 497 
b There was some overlap between the studies by Chen (2008) and Lin (2010), and between Cho (2014) and Shin 498 
(2011+2013). 499 
b The studies by Shin (2011+2013) included the same patient population, but reported different outcomes.   500 
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USA 2000 – 2011 
Age < 18 years, 
CPR duration ≥ 10 
min 
Hospitals with no E-CPR cases, 
events in the delivery room or 
rehabilitation facility or same-day 









Not Reported 70 
Ortmann, 
2011[40] 
USA 2000 – 2008 





E-CPR refers to extracorporeal cardiopulmonary resuscitation, CPR refers to cardiopulmonary resuscitation. 501 
a There was some overlap between the studies by Lasa (2016) and Ortmann (2011).  502 
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Table 4. Overview of ongoing randomized clinical trials registered online 







Hyperinvasive Approach in 






Determine the advantage 
of prehospital intra-arrest 
hypothermia, mechanical 
CPR, ECLS, and early 
invasive assessment vs. 
standard of care.   
170 
Emergency Cardiopulmonary 




Determine the feasibility of 
ECPB installed in an ED vs. 
standard of care 
40 
ECPR for Refractory Out-Of-




Determine the feasibility of 
expedited transport to an 
ED capable of initiating 
ECPR vs. standard of care 
30 
A Comparative Study 
Between a Pre-hospital and 
an In-hospital Circulatory 
Support Strategy in 




Determine the advantage 
of pre-hospital ECMO vs. in-
hospital ECMO 
210 
Early Initiation of 
Extracorporeal Life Support 




Determine the effect of 
ECPR in ED vs. standard of 
care 
110 
OHCA refers to out-of-hospital cardiac arrest, ROSC refers to return of spontaneous circulation, ECPB refers to 503 
emergency cardiopulmonary bypass, ECPR refers to extracorporeal cardiopulmonary resuscitation, ECMO refers to 504 
extracorporeal membrane oxygenation, CCPR refers to conventional cardiopulmonary resuscitation, ED refers to 505 
emergency department, CPR refers to cardiopulmonary resuscitation, ECLS refers to extracorporeal life support 506 
a All studies were registered at clinicaltrials.gov 507 
 508 
